Clinical Trials Directory

Trials / Unknown

UnknownNCT04049188

Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice

Impact of Access to Single-Fraction Palliative Radiation Therapy in Cancer Patients Enrolled in Hospice

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
31 (estimated)
Sponsor
Care Partners · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Feasibility study to report on the impact of ACCESS of single-fraction radiation therapy on cancer patients with bone metastases enrolled in hospice care.

Detailed description

Hospice care for terminally ill patients with metastatic cancer improves quality of life, pain control, and potentially also survival when patients are enrolled early.1-3 However, hospice programs are often seen by patients and their caregivers as the last resort after exhaustion of all effective treatment options. The need to revoke active treatment (for all hospice patients with cancer outside of the VA system) discourages hospice enrollment. This study aims to understand and analyze barriers to access specifically for short course palliative radiation therapy in cancer patients enrolled in hospice.

Conditions

Interventions

TypeNameDescription
RADIATIONSingle-Fraction Palliative Radiation TherapyAll subjects will be undergo single-fraction palliative radiation therapy who have cancer and associated bone metastases and symptomatic bone pain.

Timeline

Start date
2020-01-01
Primary completion
2021-01-01
Completion
2021-12-31
First posted
2019-08-08
Last updated
2020-01-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04049188. Inclusion in this directory is not an endorsement.